Immunogenicity of peptides having pre-determined alpha-helical and alpha-alpha fold topologies
- PMID: 1717836
- DOI: 10.1016/0161-5890(91)90019-g
Immunogenicity of peptides having pre-determined alpha-helical and alpha-alpha fold topologies
Abstract
A panel of three synthetic peptides based on the 310-327 region of mouse LDH-C4 was used to examine the effect of peptide conformation on immunogenicity. The peptides, without prior conjugation to carrier molecules, were injected into outbred mice and the antisera were assayed for peptide- and LDH-C4-reactive antibodies by ELISA. An 18-residue random coil peptide (alpha N) and an 18-residue amphipathic alpha-helix peptide (alpha 1) were weakly immunogenic. A conformationally stable 40-residue alpha-alpha fold peptide (alpha 3) was highly immunogenic. The antibodies elicited by alpha 3 reacted strongly with the native molecule by ELISA. Solution-phase binding assays were used to further characterize the specificity of the sera from two mice immunized with alpha 3. Antibodies from one of the mice appeared to recognize the helical portion of the peptides, while antibodies from the other mouse reacted only with the immunogen and may be specific for the non-natural beta bend residues or possibly a topographic determinant peculiar to the anti-parallel helices. Serum from neither mouse was able to recognize the native molecule in solution. Peptides intended to mimic topographic determinants for the purpose of synthetic vaccine development may have to be more complex than those used in this study in order to induce high-affinity antibodies capable of exerting a significant biological effect.
Similar articles
-
Design and immunological properties of topographic immunogenic determinants of a protein antigen (LDH-C4) as vaccines.J Biol Chem. 1992 Mar 25;267(9):6338-46. J Biol Chem. 1992. PMID: 1372905
-
Engineered topographic determinants with alpha beta, beta alpha beta, and beta alpha beta alpha topologies show high affinity binding to native protein antigen (lactate dehydrogenase-C4).J Biol Chem. 1993 Dec 5;268(34):25285-95. J Biol Chem. 1993. PMID: 8244959
-
Synthesis and biophysical characterization of engineered topographic immunogenic determinants with alpha alpha topology.Biochemistry. 1990 Jan 9;29(1):13-23. doi: 10.1021/bi00453a002. Biochemistry. 1990. PMID: 1691014
-
Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.J Mol Recognit. 1993 Jun;6(2):81-94. doi: 10.1002/jmr.300060206. J Mol Recognit. 1993. PMID: 7508238
-
Antigenic sites of lactate dehydrogenase-C4.Isozymes Curr Top Biol Med Res. 1987;14:103-22. Isozymes Curr Top Biol Med Res. 1987. PMID: 2439476 Review.
Cited by
-
Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.Biomater Sci. 2015 Jul;3(7):908-22. doi: 10.1039/C4BM00442F. Biomater Sci. 2015. PMID: 26191406 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous